Utah Medical Products, Inc.

NasdaqGS:UTMD Stock Report

Market Cap: US$236.6m

Utah Medical Products Management

Management criteria checks 3/4

We currently do not have sufficient information about the CEO.

Key information

Kevin Cornwell

Chief executive officer

US$510.6k

Total compensation

CEO salary percentage29.8%
CEO tenure31.3yrs
CEO ownership5.3%
Management average tenureno data
Board average tenure27.3yrs

Recent management updates

Recent updates

Utah Medical Products: An Attractive, But Speculative, Prospect

Mar 22

Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30

Feb 09
Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30

Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30

Dec 13
Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of $0.30

Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.30

Nov 23
Utah Medical Products' (NASDAQ:UTMD) Dividend Will Be $0.30

Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.30

Nov 03
Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.30

Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of $0.295

Aug 28
Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of $0.295

Do Utah Medical Products' (NASDAQ:UTMD) Earnings Warrant Your Attention?

Mar 04
Do Utah Medical Products' (NASDAQ:UTMD) Earnings Warrant Your Attention?

Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.295

Feb 10
Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of $0.295

A Look At The Fair Value Of Utah Medical Products, Inc. (NASDAQ:UTMD)

Jan 11
A Look At The Fair Value Of Utah Medical Products, Inc. (NASDAQ:UTMD)

Utah Medical Products (NASDAQ:UTMD) Will Pay A Dividend Of $0.29

Aug 08
Utah Medical Products (NASDAQ:UTMD) Will Pay A Dividend Of $0.29

Utah Medical Products declares $0.29 dividend

Aug 02

Utah Medical Products GAAP EPS of $1.12, revenue of $13.4M

Jul 26

Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29

May 14
Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29

Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of US$0.29

Feb 26
Utah Medical Products (NASDAQ:UTMD) Has Announced A Dividend Of US$0.29

Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29

Feb 12
Utah Medical Products (NASDAQ:UTMD) Is Due To Pay A Dividend Of US$0.29

Utah Medical Products (NASDAQ:UTMD) Could Be Struggling To Allocate Capital

Sep 28
Utah Medical Products (NASDAQ:UTMD) Could Be Struggling To Allocate Capital

Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of US$0.28

Aug 06
Utah Medical Products (NASDAQ:UTMD) Has Affirmed Its Dividend Of US$0.28

Shareholders Will Probably Not Have Any Issues With Utah Medical Products, Inc.'s (NASDAQ:UTMD) CEO Compensation

May 01
Shareholders Will Probably Not Have Any Issues With Utah Medical Products, Inc.'s (NASDAQ:UTMD) CEO Compensation

Is Utah Medical Products, Inc. (NASDAQ:UTMD) An Attractive Dividend Stock?

Mar 26
Is Utah Medical Products, Inc. (NASDAQ:UTMD) An Attractive Dividend Stock?

Here's What To Make Of Utah Medical Products' (NASDAQ:UTMD) Returns On Capital

Mar 02
Here's What To Make Of Utah Medical Products' (NASDAQ:UTMD) Returns On Capital

Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Feb 11
Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Recent Stock Performance Influenced By Its Fundamentals In Any Way?

Utah Medical Products (NASDAQ:UTMD) Shareholders Have Enjoyed A 47% Share Price Gain

Jan 27
Utah Medical Products (NASDAQ:UTMD) Shareholders Have Enjoyed A 47% Share Price Gain

Should You Review Recent Insider Transactions At Utah Medical Products, Inc. (NASDAQ:UTMD)?

Jan 13
Should You Review Recent Insider Transactions At Utah Medical Products, Inc. (NASDAQ:UTMD)?

Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Shareholder Ownership Skewed Towards Insiders?

Dec 29
Is Utah Medical Products, Inc.'s (NASDAQ:UTMD) Shareholder Ownership Skewed Towards Insiders?

Is Utah Medical Products, Inc. (NASDAQ:UTMD) A Smart Pick For Income Investors?

Dec 15
Is Utah Medical Products, Inc. (NASDAQ:UTMD) A Smart Pick For Income Investors?

Will Utah Medical Products (NASDAQ:UTMD) Multiply In Value Going Forward?

Nov 30
Will Utah Medical Products (NASDAQ:UTMD) Multiply In Value Going Forward?

Utah Medical Products declares $0.285 dividend

Nov 03

CEO Compensation Analysis

How has Kevin Cornwell's remuneration changed compared to Utah Medical Products's earnings?
DateTotal CompensationSalaryCompany Earnings
Mar 31 2024n/an/a

US$16m

Dec 31 2023US$511kUS$152k

US$17m

Sep 30 2023n/an/a

US$17m

Jun 30 2023n/an/a

US$17m

Mar 31 2023n/an/a

US$17m

Dec 31 2022US$452kUS$84k

US$16m

Sep 30 2022n/an/a

US$16m

Jun 30 2022n/an/a

US$16m

Mar 31 2022n/an/a

US$15m

Dec 31 2021US$494kUS$156k

US$15m

Sep 30 2021n/an/a

US$14m

Jun 30 2021n/an/a

US$13m

Mar 31 2021n/an/a

US$11m

Dec 31 2020US$327kUS$78k

US$11m

Sep 30 2020n/an/a

US$12m

Jun 30 2020n/an/a

US$13m

Mar 31 2020n/an/a

US$15m

Dec 31 2019US$474kUS$156k

US$15m

Sep 30 2019n/an/a

US$14m

Jun 30 2019n/an/a

US$17m

Mar 31 2019n/an/a

US$18m

Dec 31 2018US$501kUS$156k

US$19m

Sep 30 2018n/an/a

US$13m

Jun 30 2018n/an/a

US$10m

Mar 31 2018n/an/a

US$9m

Dec 31 2017US$501kUS$156k

US$9m

Compensation vs Market: Kevin's total compensation ($USD510.57K) is below average for companies of similar size in the US market ($USD1.62M).

Compensation vs Earnings: Kevin's compensation has been consistent with company performance over the past year.


CEO

Kevin Cornwell (76 yo)

31.3yrs

Tenure

US$510,570

Compensation

Mr. Kevin L. Cornwell has been the Chairman of the Board at Utah Medical Products Inc. since 1996 and its President and Chief Executive Officer since December 1992. Mr. Cornwell has been Secretary of Utah...


Board Members

NamePositionTenureCompensationOwnership
Kevin Cornwell
Chairman31.3yrsUS$510.57k5.25%
$ 12.4m
Paul Richins
Independent Director26.3yrsUS$29.40k0.60%
$ 1.4m
Ernst Hoyer
Independent Lead Director28.3yrsUS$37.80k0.14%
$ 329.6k
Barbara Payne
Independent Director27.3yrsUS$29.40k0.13%
$ 318.9k
James Beeson
Independent Director17.2yrsUS$29.40k0.37%
$ 865.2k

27.3yrs

Average Tenure

76yo

Average Age

Experienced Board: UTMD's board of directors are seasoned and experienced ( 27.3 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.